ducovest

CAH:NYE-Cardinal Health Inc (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 149.53

Change

0.00 (0.00)%

Market Cap

USD 32.54B

Volume

3.37M

Analyst Target

USD 58.94
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Company Website : https://www.cardinalhealth.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-04 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

N/A

 USD 55.55B
MCK McKesson Corporation

N/A

 N/A
OMI Owens & Minor Inc

N/A

 N/A
NVG Nuveen AMT Free Municipal Cred..

N/A

 N/A

ETFs Containing CAH

PEZ Invesco DWA Consumer Cycl.. 3.84 % 0.60 %

N/A

 USD 0.05B
RSPH Invesco S&P 500 Equal Wei.. 1.75 % 0.00 %

N/A

 USD 0.80B
IQSA:F Invesco Markets II PLC - .. 1.42 % 0.00 %

N/A

 N/A
IQSE:F Invesco Quantitative Stra.. 1.42 % 0.00 %

N/A

 N/A
MCDS JPMorgan Fundamental Data.. 1.26 % 0.00 %

N/A

 USD 4.92M
DEF 0.00 % 0.59 %

N/A

 N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

 USD 0.08B
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

N/A

 CAD 0.01B
IBDD 0.00 % 0.10 %

N/A

 N/A
JPME JPMorgan Diversified Retu.. 0.00 % 0.24 %

N/A

 USD 0.33B
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

 N/A
PWC 0.00 % 0.59 %

N/A

 N/A
QSY 0.00 % 0.38 %

N/A

 N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

 USD 0.01B
IVFVC 0.00 % 0.00 %

N/A

 N/A
VSMV VictoryShares US Multi-Fa.. 0.00 % 0.35 %

N/A

 USD 0.11B
DBLV 0.00 % 0.87 %

N/A

 N/A
RYJ Invesco Raymond James SB-.. 0.00 % 0.75 %

N/A

 N/A
CHGX Change Finance Diversifie.. 0.00 % 0.64 %

N/A

 USD 0.11B
GBDV 0.00 % 0.00 %

N/A

 N/A
JPGL:LSE JPM Global Equity Multi-F.. 0.00 % 0.00 %

N/A

 USD 0.19B
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

 CAD 0.01B
STNC Hennessy Stance ESG ETF 0.00 % 0.00 %

N/A

 USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.43% 80% B- 97% N/A
Dividend Return 0.85% 67% D+ 39% F
Total Return 27.29% 80% B- 97% N/A
Trailing 12 Months  
Capital Gain 51.18% 100% F 96% N/A
Dividend Return 2.05% 75% C 40% F
Total Return 53.22% 100% F 96% N/A
Trailing 5 Years  
Capital Gain 215.13% 80% B- 90% A-
Dividend Return 20.90% 80% B- 54% F
Total Return 236.04% 80% B- 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 21.33% 80% B- 85% B
Dividend Return 24.32% 80% B- 85% B
Total Return 2.99% 100% F 63% D
Risk Return Profile  
Volatility (Standard Deviation) 22.93% 40% F 44% F
Risk Adjusted Return 106.05% 60% D- 96% N/A
Market Capitalization 32.54B 50% F 94% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector